{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T20:10:13Z","timestamp":1794859813818,"version":"4.9.1"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Pressure overload initiates a series of alterations in the human heart that predate macroscopic organ-level remodeling and downstream heart failure. We study aortic stenosis through integrated proteomic, tissue transcriptomic, and genetic methods to prioritize targets causal in human heart failure. First, we identify the circulating proteome of cardiac remodeling in aortic stenosis, specifying known and previously-unknown mediators of fibrosis, hypertrophy, and oxidative stress, several associated with interstitial fibrosis in a separate cohort (<jats:italic>N<\/jats:italic>\u2009=\u2009145). These signatures are strongly related to clinical outcomes in aortic stenosis (<jats:italic>N<\/jats:italic>\u2009=\u2009802) and in broader at-risk populations in the UK Biobank (<jats:italic>N<\/jats:italic>\u2009=\u200936,668). We next map this remodeling proteome to myocardial transcription in patients with and without aortic stenosis through single-nuclear transcriptomics, observing broad differential expression of genes encoding this remodeling proteome, featuring fibrosis pathways and metabolic-inflammatory signaling. Finally, integrating our circulating and tissue-specific results with modern genetic approaches, we implicate several targets as causal in heart failure.<\/jats:p>","DOI":"10.1038\/s41467-025-62201-2","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:11:35Z","timestamp":1753488695000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Integrated multiomics of pressure overload in the human heart prioritizes targets relevant to heart failure"],"prefix":"10.1038","volume":"16","author":[{"given":"Brian R.","family":"Lindman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3342-6158","authenticated-orcid":false,"given":"Andrew S.","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle L.","family":"Lance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushik","family":"Amancherla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namju","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8951-9295","authenticated-orcid":false,"given":"Quanhu","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan D.","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0281-3796","authenticated-orcid":false,"given":"Eric","family":"Farber-Eger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William F.","family":"Fearon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Kapadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharam J.","family":"Kumbhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Gillam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0892-7102","authenticated-orcid":false,"given":"Ravinder R.","family":"Mallugari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis J.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Vatterott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan Ru","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6576-8933","authenticated-orcid":false,"given":"Kelsey","family":"Tomasek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"Absi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane E.","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Nayor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4521-4606","authenticated-orcid":false,"given":"Saumya","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quinn S.","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc R.","family":"Dweck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6767-7687","authenticated-orcid":false,"given":"Robert E.","family":"Gerszten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4204-8734","authenticated-orcid":false,"given":"Eric R.","family":"Gamazon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan R.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4471-7156","authenticated-orcid":false,"given":"Ravi","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8013-8733","authenticated-orcid":false,"given":"Sammy","family":"Elmariah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,26]]},"reference":[{"key":"62201_CR1","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.jcmg.2016.10.007","volume":"10","author":"CWL Chin","year":"2017","unstructured":"Chin, C. W. L. et al. Myocardial fibrosis and cardiac decompensation in aortic stenosis. JACC Cardiovasc. Imaging 10, 1320\u20131333 (2017).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"62201_CR2","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/j.jcmg.2019.02.034","volume":"12","author":"TA Treibel","year":"2019","unstructured":"Treibel, T. A., Badiani, S., Lloyd, G. & Moon, J. C. Multimodality imaging markers of adverse myocardial remodeling in aortic stenosis. JACC Cardiovasc. Imaging 12, 1532\u20131548 (2019).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"62201_CR3","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1016\/j.jcmg.2019.05.032","volume":"12","author":"M Mahmod","year":"2019","unstructured":"Mahmod, M. et al. Histological evidence for impaired myocardial perfusion reserve in severe aortic stenosis. JACC Cardiovasc. Imaging 12, 2276\u20132278 (2019).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"62201_CR4","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jcmg.2019.08.008","volume":"13","author":"A Singh","year":"2020","unstructured":"Singh, A. et al. Determinants of exercise capacity and myocardial perfusion reserve in asymptomatic patients with aortic stenosis. JACC Cardiovasc. Imaging 13, 178\u2013180 (2020).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"62201_CR5","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.jcin.2020.03.011","volume":"13","author":"H Gonzales","year":"2020","unstructured":"Gonzales, H. et al. Left ventricular hypertrophy and clinical outcomes over 5 years after TAVR: an analysis of the PARTNER trials and registries. JACC Cardiovasc. Inter. 13, 1329\u20131339 (2020).","journal-title":"JACC Cardiovasc. Inter."},{"key":"62201_CR6","doi-asserted-by":"publisher","first-page":"4843","DOI":"10.1172\/JCI95945","volume":"128","author":"DM Abraham","year":"2018","unstructured":"Abraham, D. M. et al. The two-pore domain potassium channel TREK-1 mediates cardiac fibrosis and diastolic dysfunction. J. Clin. Invest. 128, 4843\u20134855 (2018).","journal-title":"J. Clin. Invest."},{"key":"62201_CR7","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1161\/CIRCRESAHA.121.319737","volume":"129","author":"XS Revelo","year":"2021","unstructured":"Revelo, X. S. et al. Cardiac resident macrophages prevent fibrosis and stimulate angiogenesis. Circ. Res. 129, 1086\u20131101 (2021).","journal-title":"Circ. Res."},{"key":"62201_CR8","doi-asserted-by":"publisher","first-page":"5004","DOI":"10.1021\/pr800409u","volume":"7","author":"C Cieniewski-Bernard","year":"2008","unstructured":"Cieniewski-Bernard, C. et al. Proteomic analysis of left ventricular remodeling in an experimental model of heart failure. J. Proteome Res. 7, 5004\u20135016 (2008).","journal-title":"J. Proteome Res."},{"key":"62201_CR9","doi-asserted-by":"crossref","first-page":"e010255","DOI":"10.1161\/CIRCHEARTFAILURE.122.010255","volume":"16","author":"AM van Ommen","year":"2023","unstructured":"van Ommen, A. M. et al. Plasma proteomic patterns show sex differences in early concentric left ventricular remodeling. Circ. Heart Fail 16, e010255 (2023).","journal-title":"Circ. Heart Fail"},{"key":"62201_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-24226-1","volume":"12","author":"JA Regan","year":"2022","unstructured":"Regan, J. A. et al. Protein biomarkers of cardiac remodeling and inflammation associated with HFpEF and incident events. Sci. Rep. 12, 20072 (2022).","journal-title":"Sci. Rep."},{"key":"62201_CR11","doi-asserted-by":"publisher","first-page":"e006749","DOI":"10.1161\/CIRCHEARTFAILURE.119.006749","volume":"13","author":"M Nayor","year":"2020","unstructured":"Nayor, M. et al. Aptamer-based proteomic platform identifies novel protein predictors of incident heart failure and echocardiographic traits. Circ. Heart Fail 13, e006749 (2020).","journal-title":"Circ. Heart Fail"},{"key":"62201_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13306-y","volume":"10","author":"A Egerstedt","year":"2019","unstructured":"Egerstedt, A. et al. Profiling of the plasma proteome across different stages of human heart failure. Nat. Commun. 10, 5830 (2019).","journal-title":"Nat. Commun."},{"key":"62201_CR13","doi-asserted-by":"publisher","first-page":"e003140","DOI":"10.1161\/CIRCGEN.120.003140","volume":"14","author":"H Gui","year":"2021","unstructured":"Gui, H. et al. Plasma proteomic profile predicts survival in heart failure with reduced ejection fraction. Circ. Genom. Precis Med. 14, e003140 (2021).","journal-title":"Circ. Genom. Precis Med."},{"key":"62201_CR14","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1016\/j.jacc.2020.08.061","volume":"76","author":"L Adamo","year":"2020","unstructured":"Adamo, L. et al. Proteomic signatures of heart failure in relation to left ventricular ejection fraction. J. Am. Coll. Cardiol. 76, 1982\u20131994 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"62201_CR15","doi-asserted-by":"publisher","first-page":"e005897","DOI":"10.1161\/CIRCHEARTFAILURE.118.005897","volume":"12","author":"JP Ferreira","year":"2019","unstructured":"Ferreira, J. P. et al. Proteomic bioprofiles and mechanistic pathways of progression to heart failure. Circ. Heart Fail 12, e005897 (2019).","journal-title":"Circ. Heart Fail"},{"key":"62201_CR16","doi-asserted-by":"publisher","first-page":"e003191","DOI":"10.1161\/CIRCGEN.120.003191","volume":"14","author":"DH Katz","year":"2021","unstructured":"Katz, D. H. et al. Multiomic profiling in black and white populations reveals novel candidate pathways in left ventricular hypertrophy and incident heart failure specific to black adults. Circ. Genom. Precis Med. 14, e003191 (2021).","journal-title":"Circ. Genom. Precis Med."},{"key":"62201_CR17","doi-asserted-by":"publisher","first-page":"16006","DOI":"10.1038\/nrdp.2016.6","volume":"2","author":"BR Lindman","year":"2016","unstructured":"Lindman, B. R. et al. Calcific aortic stenosis. Nat. Rev. Dis. Prim. 2, 16006 (2016).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"62201_CR18","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.jacc.2013.05.015","volume":"62","author":"RL Osnabrugge","year":"2013","unstructured":"Osnabrugge, R. L. et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J. Am. Coll. Cardiol. 62, 1002\u20131012 (2013).","journal-title":"J. Am. Coll. Cardiol."},{"key":"62201_CR19","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1093\/eurheartj\/ehy107","volume":"39","author":"AP Durko","year":"2018","unstructured":"Durko, A. P. et al. Annual number of candidates for transcatheter aortic valve implantation per country: current estimates and future projections. Eur. Heart J. 39, 2635\u20132642 (2018).","journal-title":"Eur. Heart J."},{"key":"62201_CR20","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1016\/j.jacc.2014.04.018","volume":"63","author":"S Coffey","year":"2014","unstructured":"Coffey, S., Cox, B. & Williams, M. J. The prevalence, incidence, progression, and risks of aortic valve sclerosis: a systematic review and meta-analysis. J. Am. Coll. Cardiol. 63, 2852\u20132861 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"62201_CR21","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1136\/heartjnl-2012-302265","volume":"99","author":"GW Eveborn","year":"2013","unstructured":"Eveborn, G. W., Schirmer, H., Heggelund, G., Lunde, P. & Rasmussen, K. The evolving epidemiology of valvular aortic stenosis. the Tromso study. Heart 99, 396\u2013400 (2013).","journal-title":"Heart"},{"key":"62201_CR22","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.3390\/biomedicines11082131","volume":"11","author":"JM Inacio","year":"2023","unstructured":"Inacio, J. M. et al. Myocardial RNA sequencing reveals new potential therapeutic targets in heart failure with preserved ejection fraction. Biomedicines 11, 2131 (2023).","journal-title":"Biomedicines"},{"key":"62201_CR23","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s44161-022-00019-7","volume":"1","author":"L Nicin","year":"2022","unstructured":"Nicin, L. et al. A human cell atlas of the pressure-induced hypertrophic heart. Nat. Cardiovasc. Res. 1, 174\u2013185 (2022).","journal-title":"Nat. Cardiovasc. Res."},{"key":"62201_CR24","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41586-023-06802-1","volume":"624","author":"HS Oh","year":"2023","unstructured":"Oh, H. S. et al. Organ aging signatures in the plasma proteome track health and disease. Nature 624, 164\u2013172 (2023).","journal-title":"Nature"},{"key":"62201_CR25","doi-asserted-by":"publisher","first-page":"eaau8680","DOI":"10.1126\/scitranslmed.aau8680","volume":"11","author":"JD Roh","year":"2019","unstructured":"Roh, J. D. et al. Activin type II receptor signaling in cardiac aging and heart failure. Sci. Transl. Med. 11, eaau8680 (2019).","journal-title":"Sci. Transl. Med."},{"key":"62201_CR26","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1002\/ehf2.12728","volume":"7","author":"M Wesseling","year":"2020","unstructured":"Wesseling, M., de Poel, J. H. C. & de Jager, S. C. A. Growth differentiation factor 15 in adverse cardiac remodelling: from biomarker to causal player. ESC Heart Fail 7, 1488\u20131501 (2020).","journal-title":"ESC Heart Fail"},{"key":"62201_CR27","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jchf.2022.09.004","volume":"11","author":"C Adamson","year":"2023","unstructured":"Adamson, C. et al. IGFBP-7 and outcomes in heart failure with reduced ejection fraction. Find. DAPA-Hf. JACC Heart Fail. 11, 291\u2013304 (2023).","journal-title":"Find. DAPA-Hf. JACC Heart Fail."},{"key":"62201_CR28","doi-asserted-by":"publisher","first-page":"e005133","DOI":"10.1161\/CIRCHEARTFAILURE.118.005133","volume":"11","author":"JL Januzzi Jr.","year":"2018","unstructured":"Januzzi, J. L. Jr. et al. IGFBP7 (insulin-like growth factor-binding protein-7) and neprilysin inhibition in patients with heart failure. Circ. Heart Fail 11, e005133 (2018).","journal-title":"Circ. Heart Fail"},{"key":"62201_CR29","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1002\/ehf2.12590","volume":"7","author":"AA Konev","year":"2020","unstructured":"Konev, A. A. et al. CT-IGFBP-4 as a novel prognostic biomarker in acute heart failure. ESC Heart Fail 7, 434\u2013444 (2020).","journal-title":"ESC Heart Fail"},{"key":"62201_CR30","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.7150\/ijms.60685","volume":"18","author":"Q Du","year":"2021","unstructured":"Du, Q. et al. The molecular genetics of marfan syndrome. Int. J. Med. Sci. 18, 2752\u20132766 (2021).","journal-title":"Int. J. Med. Sci."},{"key":"62201_CR31","doi-asserted-by":"publisher","first-page":"e13377","DOI":"10.1111\/apha.13377","volume":"228","author":"XF Pang","year":"2020","unstructured":"Pang, X. F., Lin, X., Du, J. J. & Zeng, D. Y. LTBP2 knockdown by siRNA reverses myocardial oxidative stress injury, fibrosis and remodelling during dilated cardiomyopathy. Acta Physiol. (Oxf.) 228, e13377 (2020).","journal-title":"Acta Physiol. (Oxf.)"},{"key":"62201_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14263-2","volume":"11","author":"FC Simoes","year":"2020","unstructured":"Simoes, F. C. et al. Macrophages directly contribute collagen to scar formation during zebrafish heart regeneration and mouse heart repair. Nat. Commun. 11, 600 (2020).","journal-title":"Nat. Commun."},{"key":"62201_CR33","doi-asserted-by":"publisher","first-page":"866","DOI":"10.4103\/1673-5374.158332","volume":"10","author":"Korpos E","year":"2015","unstructured":"Korpos E, Deak, F. & Kiss, I. Matrilin-2, an extracellular adaptor protein, is needed for the regeneration of muscle, nerve and other tissues. Neural Regen. Res. 10, 866\u2013869 (2015).","journal-title":"Neural Regen. Res."},{"key":"62201_CR34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41586-022-04989-3","volume":"608","author":"MC Hill","year":"2022","unstructured":"Hill, M. C. et al. Integrated multi-omic characterization of congenital heart disease. Nature 608, 181\u2013191 (2022).","journal-title":"Nature"},{"key":"62201_CR35","first-page":"1","volume":"1","author":"L Yang","year":"2019","unstructured":"Yang, L. et al. Crim1 suppresses left ventricular hypertrophy. Biomed. Rep. 1, 1\u20135 (2019).","journal-title":"Biomed. Rep."},{"key":"62201_CR36","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","volume":"126","author":"M Gheblawi","year":"2020","unstructured":"Gheblawi, M. et al. Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circ. Res. 126, 1456\u20131474 (2020).","journal-title":"Circ. Res."},{"key":"62201_CR37","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.jacc.2011.03.064","volume":"58","author":"MR Dweck","year":"2011","unstructured":"Dweck, M. R. et al. Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J. Am. Coll. Cardiol. 58, 1271\u20131279 (2011).","journal-title":"J. Am. Coll. Cardiol."},{"key":"62201_CR38","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jcmg.2018.11.026","volume":"12","author":"R Bing","year":"2019","unstructured":"Bing, R. et al. Imaging and impact of myocardial fibrosis in aortic stenosis. JACC Cardiovasc Imaging 12, 283\u2013296 (2019).","journal-title":"JACC Cardiovasc Imaging"},{"key":"62201_CR39","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jcmg.2018.06.026","volume":"12","author":"M Dweck","year":"2019","unstructured":"Dweck, M. & Bing, R. Diffuse myocardial fibrosis in aortic stenosis: Time to Act? JACC Cardiovasc. Imaging 12, 120\u2013122 (2019).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"62201_CR40","doi-asserted-by":"publisher","unstructured":"Loganath, K. et al. Early intervention in patients with asymptomatic severe aortic stenosis and myocardial fibrosis: the EVOLVED randomized clinical trial. JAMA. https:\/\/doi.org\/10.1001\/jama.2024.22730 (2024).","DOI":"10.1001\/jama.2024.22730"},{"key":"62201_CR41","doi-asserted-by":"publisher","first-page":"eabo0699","DOI":"10.1126\/scitranslmed.abo0699","volume":"14","author":"G Ruozi","year":"2022","unstructured":"Ruozi, G. et al. Cardioprotective factors against myocardial infarction selected in vivo from an AAV secretome library. Sci. Transl. Med. 14, eabo0699 (2022).","journal-title":"Sci. Transl. Med."},{"key":"62201_CR42","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.bbrc.2015.09.121","volume":"467","author":"T Adachi","year":"2015","unstructured":"Adachi, T. et al. Roles of layilin in TNF-alpha-induced epithelial-mesenchymal transformation of renal tubular epithelial cells. Biochem. Biophys. Res. Commun. 467, 63\u201369 (2015).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"62201_CR43","doi-asserted-by":"publisher","first-page":"100887","DOI":"10.1016\/j.jbc.2021.100887","volume":"297","author":"B Zhang","year":"2021","unstructured":"Zhang, B. et al. Trefoil factor 2 secreted from damaged hepatocytes activates hepatic stellate cells to induce fibrogenesis. J. Biol. Chem. 297, 100887 (2021).","journal-title":"J. Biol. Chem."},{"key":"62201_CR44","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1681\/ASN.2017050574","volume":"29","author":"C Luo","year":"2018","unstructured":"Luo, C. et al. Wnt9a promotes renal fibrosis by accelerating cellular senescence in tubular epithelial cells. J. Am. Soc. Nephrol. 29, 1238\u20131256 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"62201_CR45","doi-asserted-by":"publisher","unstructured":"Yuan, J. et al. miR-542-5p attenuates fibroblast activation by targeting integrin alpha6 in Silica-induced pulmonary fibrosis. Int. J. Mol. Sci. 19 https:\/\/doi.org\/10.3390\/ijms19123717 (2018).","DOI":"10.3390\/ijms19123717"},{"key":"62201_CR46","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1172\/JCI71386","volume":"124","author":"MW Parker","year":"2014","unstructured":"Parker, M. W. et al. Fibrotic extracellular matrix activates a profibrotic positive feedback loop. J. Clin. Invest. 124, 1622\u20131635 (2014).","journal-title":"J. Clin. Invest."},{"key":"62201_CR47","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3109\/1354750X.2014.896946","volume":"19","author":"E Eleuteri","year":"2014","unstructured":"Eleuteri, E. et al. Fibrosis markers and CRIM1 increase in chronic heart failure of increasing severity. Biomarkers 19, 214\u2013221 (2014).","journal-title":"Biomarkers"},{"key":"62201_CR48","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1093\/ndt\/gfq619","volume":"26","author":"R Zeng","year":"2011","unstructured":"Zeng, R. et al. Role of Sema4C in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. Nephrol. Dial. Transpl. 26, 1149\u20131156 (2011).","journal-title":"Nephrol. Dial. Transpl."},{"key":"62201_CR49","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3389\/fmed.2018.00180","volume":"5","author":"I Ninou","year":"2018","unstructured":"Ninou, I., Magkrioti, C. & Aidinis, V. Autotaxin in pathophysiology and pulmonary fibrosis. Front. Med. (Lausanne) 5, 180 (2018).","journal-title":"Front. Med. (Lausanne)"},{"key":"62201_CR50","doi-asserted-by":"publisher","first-page":"18653","DOI":"10.1002\/jcp.28503","volume":"234","author":"Y Cai","year":"2019","unstructured":"Cai, Y., Xie, K. L., Wu, H. L. & Wu, K. Functional suppression of Epiregulin impairs angiogenesis and aggravates left ventricular remodeling by disrupting the extracellular-signal-regulated kinase1\/2 signaling pathway in rats after acute myocardial infarction. J. Cell Physiol. 234, 18653\u201318665 (2019).","journal-title":"J. Cell Physiol."},{"key":"62201_CR51","doi-asserted-by":"publisher","first-page":"617671","DOI":"10.3389\/fimmu.2021.617671","volume":"12","author":"F Maccarinelli","year":"2021","unstructured":"Maccarinelli, F. et al. Endogenous long pentraxin 3 exerts a protective role in a murine model of pulmonary fibrosis. Front. Immunol. 12, 617671 (2021).","journal-title":"Front. Immunol."},{"key":"62201_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1099","volume":"12","author":"JY Chi","year":"2022","unstructured":"Chi, J. Y. et al. Blockade of the pentraxin 3\/CD44 interaction attenuates lung injury-induced fibrosis. Clin. Transl. Med. 12, e1099 (2022).","journal-title":"Clin. Transl. Med."},{"key":"62201_CR53","doi-asserted-by":"publisher","first-page":"4036","DOI":"10.18632\/aging.204070","volume":"14","author":"Y Xu","year":"2022","unstructured":"Xu, Y. et al. Pentraxin 3 depletion (PTX3 KD) inhibited myocardial fibrosis in heart failure after myocardial infarction. Aging 14, 4036\u20134049 (2022).","journal-title":"Aging"},{"key":"62201_CR54","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3390\/antiox11030555","volume":"11","author":"SW Ryter","year":"2022","unstructured":"Ryter, S. W. Heme oxygenase-1: an anti-inflammatory effector in cardiovascular, lung, and related metabolic disorders. Antioxidants 11, 555 (2022).","journal-title":"Antioxidants"},{"key":"62201_CR55","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.3390\/biom11071047","volume":"11","author":"K Shirakawa","year":"2021","unstructured":"Shirakawa, K. & Sano, M. Osteopontin in cardiovascular diseases. Biomolecules 11, 1047 (2021).","journal-title":"Biomolecules"},{"key":"62201_CR56","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.7150\/thno.78736","volume":"13","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. Hypoxia induces M2 macrophages to express VSIG4 and mediate cardiac fibrosis after myocardial infarction. Theranostics 13, 2192\u20132209 (2023).","journal-title":"Theranostics"},{"key":"62201_CR57","doi-asserted-by":"publisher","first-page":"e125074","DOI":"10.1172\/jci.insight.125074","volume":"5","author":"SA Bageghni","year":"2019","unstructured":"Bageghni, S. A. et al. Fibroblast-specific deletion of interleukin-1 receptor-1 reduces adverse cardiac remodeling following myocardial infarction. JCI Insight 5, e125074 (2019).","journal-title":"JCI Insight"},{"key":"62201_CR58","doi-asserted-by":"publisher","first-page":"eadd4222","DOI":"10.1126\/sciadv.add4222","volume":"9","author":"L Meng","year":"2023","unstructured":"Meng, L. et al. NPRC deletion attenuates cardiac fibrosis in diabetic mice by activating PKA\/PKG and inhibiting TGF-beta1\/Smad pathways. Sci. Adv. 9, eadd4222 (2023).","journal-title":"Sci. Adv."},{"key":"62201_CR59","doi-asserted-by":"publisher","first-page":"H784","DOI":"10.1152\/ajpheart.00411.2021","volume":"321","author":"TN Audam","year":"2021","unstructured":"Audam, T. N. et al. Cardiac PANK1 deletion exacerbates ventricular dysfunction during pressure overload. Am. J. Physiol. Heart Circ. Physiol. 321, H784\u2013H797 (2021).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"62201_CR60","doi-asserted-by":"publisher","unstructured":"Forelli, N. et al. SGLT2 inhibitors activate pantothenate kinase in the human heart. Preprint at bioRxiv. https:\/\/doi.org\/10.1101\/2024.07.26.605401 (2024).","DOI":"10.1101\/2024.07.26.605401"},{"key":"62201_CR61","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1161\/CIRCULATIONAHA.119.045401","volume":"142","author":"NR Tucker","year":"2020","unstructured":"Tucker, N. R. et al. Transcriptional and cellular diversity of the human heart. Circulation 142, 466\u2013482 (2020).","journal-title":"Circulation"},{"key":"62201_CR62","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1161\/HYPERTENSIONAHA.113.01506","volume":"63","author":"DS Jiang","year":"2014","unstructured":"Jiang, D. S. et al. Signal regulatory protein-alpha protects against cardiac hypertrophy via the disruption of toll-like receptor 4 signaling. Hypertension 63, 96\u2013104 (2014).","journal-title":"Hypertension"},{"key":"62201_CR63","doi-asserted-by":"publisher","first-page":"E1345","DOI":"10.1073\/pnas.1615105114","volume":"114","author":"MH Jeong","year":"2017","unstructured":"Jeong, M. H. et al. Cdon deficiency causes cardiac remodeling through hyperactivation of WNT\/beta-catenin signaling. Proc. Natl. Acad. Sci. USA 114, E1345\u2013E1354 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62201_CR64","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1080\/15548627.2022.2160565","volume":"19","author":"L Montegut","year":"2023","unstructured":"Montegut, L. et al. DBI\/ACBP is a targetable autophagy checkpoint involved in aging and cardiovascular disease. Autophagy 19, 2166\u20132169 (2023).","journal-title":"Autophagy"},{"key":"62201_CR65","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.molmed.2019.05.010","volume":"25","author":"B Aryal","year":"2019","unstructured":"Aryal, B., Price, N. L., Suarez, Y. & Fernandez-Hernando, C. ANGPTL4 in metabolic and cardiovascular disease. Trends Mol. Med. 25, 723\u2013734 (2019).","journal-title":"Trends Mol. Med."},{"key":"62201_CR66","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.bbrc.2015.04.032","volume":"461","author":"S Zhang","year":"2015","unstructured":"Zhang, S. et al. PDCD5 protects against cardiac remodeling by regulating autophagy and apoptosis. Biochem. Biophys. Res. Commun. 461, 321\u2013328 (2015).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"62201_CR67","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/s42003-022-04034-z","volume":"5","author":"N Neupane","year":"2022","unstructured":"Neupane, N. et al. Inter-organellar and systemic responses to impaired mitochondrial matrix protein import in skeletal muscle. Commun. Biol. 5, 1060 (2022).","journal-title":"Commun. Biol."},{"key":"62201_CR68","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1161\/CIRCULATIONAHA.107.729125","volume":"117","author":"A Zernecke","year":"2008","unstructured":"Zernecke, A., Bernhagen, J. & Weber, C. Macrophage migration inhibitory factor in cardiovascular disease. Circulation 117, 1594\u20131602 (2008).","journal-title":"Circulation"},{"key":"62201_CR69","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1161\/CIRCRESAHA.107.157859","volume":"102","author":"MM Montano","year":"2008","unstructured":"Montano, M. M. et al. Mutation of the HEXIM1 gene results in defects during heart and vascular development partly through downregulation of vascular endothelial growth factor. Circ. Res. 102, 415\u2013422 (2008).","journal-title":"Circ. Res."},{"key":"62201_CR70","doi-asserted-by":"publisher","first-page":"e029003","DOI":"10.1161\/JAHA.122.029003","volume":"12","author":"X Wang","year":"2023","unstructured":"Wang, X., Huang, T. & Jia, J. Proteome-wide mendelian randomization analysis identified potential drug targets for atrial fibrillation. J. Am. Heart Assoc. 12, e029003 (2023).","journal-title":"J. Am. Heart Assoc."},{"key":"62201_CR71","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.7150\/ijbs.59965","volume":"17","author":"X Ma","year":"2021","unstructured":"Ma, X. et al. GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential. Int. J. Biol. Sci. 17, 2050\u20132068 (2021).","journal-title":"Int. J. Biol. Sci."},{"key":"62201_CR72","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12933-023-01970-w","volume":"22","author":"E Carluccio","year":"2023","unstructured":"Carluccio, E. et al. Left ventricular remodeling response to SGLT2 inhibitors in heart failure: an updated meta-analysis of randomized controlled studies. Cardiovasc. Diabetol. 22, 235 (2023).","journal-title":"Cardiovasc. Diabetol."},{"key":"62201_CR73","doi-asserted-by":"publisher","first-page":"104490","DOI":"10.1016\/j.ebiom.2023.104490","volume":"90","author":"H Bakhshi","year":"2023","unstructured":"Bakhshi, H. et al. Association between proteomic biomarkers and myocardial fibrosis measured by MRI: the multi-ethnic study of atherosclerosis. EBioMedicine 90, 104490 (2023).","journal-title":"EBioMedicine"},{"key":"62201_CR74","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s10735-020-09905-5","volume":"51","author":"J Lim","year":"2020","unstructured":"Lim, J. et al. Lipid mass spectrometry imaging and proteomic analysis of severe aortic stenosis. J. Mol. Histol. 51, 559\u2013571 (2020).","journal-title":"J. Mol. Histol."},{"key":"62201_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4137\/CMC.S3884","volume":"4","author":"F Gil-Dones","year":"2010","unstructured":"Gil-Dones, F. et al. Valvular aortic stenosis: a proteomic insight. Clin. Med. Insights Cardiol. 4, 1\u20137 (2010).","journal-title":"Clin. Med. Insights Cardiol."},{"key":"62201_CR76","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1161\/CIRCULATIONAHA.117.032291","volume":"138","author":"F Schlotter","year":"2018","unstructured":"Schlotter, F. et al. Spatiotemporal multi-omics mapping generates a molecular atlas of the aortic valve and reveals networks driving disease. Circulation 138, 377\u2013393 (2018).","journal-title":"Circulation"},{"key":"62201_CR77","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/j.jprot.2011.11.036","volume":"75","author":"F Gil-Dones","year":"2012","unstructured":"Gil-Dones, F. et al. Inside human aortic stenosis: a proteomic analysis of plasma. J. Proteom. 75, 1639\u20131653 (2012).","journal-title":"J. Proteom."},{"key":"62201_CR78","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1161\/CIRCULATIONAHA.117.030414","volume":"138","author":"J Ljungberg","year":"2018","unstructured":"Ljungberg, J. et al. Proteomic biomarkers for incident aortic stenosis requiring valvular replacement. Circulation 138, 590\u2013599 (2018).","journal-title":"Circulation"},{"key":"62201_CR79","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1161\/CIRCULATIONAHA.119.045158","volume":"142","author":"MY Chan","year":"2020","unstructured":"Chan, M. Y. et al. Prioritizing candidates of post-myocardial infarction heart failure using plasma proteomics and single-cell transcriptomics. Circulation 142, 1408\u20131421 (2020).","journal-title":"Circulation"},{"key":"62201_CR80","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrg3185","volume":"13","author":"C Vogel","year":"2012","unstructured":"Vogel, C. & Marcotte, E. M. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat. Rev. Genet. 13, 227\u2013232 (2012).","journal-title":"Nat. Rev. Genet."},{"key":"62201_CR81","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1161\/CIRCULATIONAHA.113.003863","volume":"129","author":"KC Yang","year":"2014","unstructured":"Yang, K. C. et al. Deep RNA sequencing reveals dynamic regulation of myocardial noncoding RNAs in failing human heart and remodeling with mechanical circulatory support. Circulation 129, 1009\u20131021 (2014).","journal-title":"Circulation"},{"key":"62201_CR82","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1161\/CIRCULATIONAHA.120.050498","volume":"143","author":"VS Hahn","year":"2021","unstructured":"Hahn, V. S. et al. Myocardial gene expression signatures in human heart failure with preserved ejection fraction. Circulation 143, 120\u2013134 (2021).","journal-title":"Circulation"},{"key":"62201_CR83","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41586-024-07316-0","volume":"629","author":"EV Minikel","year":"2024","unstructured":"Minikel, E. V., Painter, J. L., Dong, C. C. & Nelson, M. R. Refining the impact of genetic evidence on clinical success. Nature 629, 624\u2013629 (2024).","journal-title":"Nature"},{"key":"62201_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yjmcc.2022.08.363","volume":"173","author":"S Brandenburg","year":"2022","unstructured":"Brandenburg, S. et al. Direct proteomic and high-resolution microscopy biopsy analysis identifies distinct ventricular fates in severe aortic stenosis. J. Mol. Cell Cardiol. 173, 1\u201315 (2022).","journal-title":"J. Mol. Cell Cardiol."},{"key":"62201_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39253-3","volume":"14","author":"D Rasooly","year":"2023","unstructured":"Rasooly, D. et al. Genome-wide association analysis and Mendelian randomization proteomics identify drug targets for heart failure. Nat. Commun. 14, 3826 (2023).","journal-title":"Nat. Commun."},{"key":"62201_CR86","doi-asserted-by":"publisher","first-page":"e026529","DOI":"10.1161\/JAHA.122.026529","volume":"11","author":"AS Perry","year":"2022","unstructured":"Perry, A. S. et al. Global longitudinal strain and biomarkers of cardiac damage and stress as predictors of outcomes after transcatheter aortic valve implantation. J. Am. Heart Assoc. 11, e026529 (2022).","journal-title":"J. Am. Heart Assoc."},{"key":"62201_CR87","doi-asserted-by":"publisher","first-page":"e023466","DOI":"10.1161\/JAHA.121.023466","volume":"11","author":"EJ Stein","year":"2022","unstructured":"Stein, E. J. et al. Left ventricular hypertrophy and biomarkers of cardiac damage and stress in aortic stenosis. J. Am. Heart Assoc. 11, e023466 (2022).","journal-title":"J. Am. Heart Assoc."},{"key":"62201_CR88","doi-asserted-by":"publisher","first-page":"e029542","DOI":"10.1161\/JAHA.123.029542","volume":"12","author":"AS Perry","year":"2023","unstructured":"Perry, A. S. et al. Metabolic signatures of cardiac dysfunction, multimorbidity, and post-transcatheter aortic valve implantation death. J. Am. Heart Assoc. 12, e029542 (2023).","journal-title":"J. Am. Heart Assoc."},{"key":"62201_CR89","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","volume":"43","author":"A Vahanian","year":"2022","unstructured":"Vahanian, A. et al. 2021 ESC\/EACTS guidelines for the management of valvular heart disease. Eur. Heart J. 43, 561\u2013632 (2022).","journal-title":"Eur. Heart J."},{"key":"62201_CR90","first-page":"e72","volume":"143","author":"CM Otto","year":"2021","unstructured":"Otto, C. M. et al. 2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the american college of cardiology\/American heart association joint committee on clinical practice guidelines. Circulation 143, e72\u2013e227 (2021).","journal-title":"Circulation"},{"key":"62201_CR91","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.echo.2017.02.009","volume":"30","author":"H Baumgartner","year":"2017","unstructured":"Baumgartner, H. et al. Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European association of cardiovascular imaging and the American society of echocardiography. J. Am. Soc. Echocardiogr. 30, 372\u2013392 (2017).","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"62201_CR92","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","volume":"29","author":"SF Nagueh","year":"2016","unstructured":"Nagueh, S. F. et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American society of echocardiography and the European association of cardiovascular imaging. J. Am. Soc. Echocardiogr. 29, 277\u2013314 (2016).","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"62201_CR93","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.jacc.2019.11.032","volume":"75","author":"RJ Everett","year":"2020","unstructured":"Everett, R. J. et al. Extracellular myocardial volume in patients with aortic stenosis. J. Am. Coll. Cardiol. 75, 304\u2013316 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"62201_CR94","doi-asserted-by":"publisher","first-page":"e007451","DOI":"10.1161\/CIRCIMAGING.117.007451","volume":"11","author":"RJ Everett","year":"2018","unstructured":"Everett, R. J. et al. Progression of hypertrophy and myocardial fibrosis in aortic stenosis: a multicenter cardiac magnetic resonance study. Circ. Cardiovasc. Imaging 11, e007451 (2018).","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"62201_CR95","unstructured":"UK Biobank. Protocol for a large-scale prospective epidemiological resource. www.ukbiobank.ac.uk\/resources\/ (2006)."},{"key":"62201_CR96","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun, B. B. et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature 622, 329\u2013338 (2023).","journal-title":"Nature"},{"key":"62201_CR97","doi-asserted-by":"publisher","unstructured":"Perry, A. S. et al. Proteomic architecture of frailty across the spectrum of cardiovascular disease. Aging Cell. https:\/\/doi.org\/10.1111\/acel.13978 (2023).","DOI":"10.1111\/acel.13978"},{"key":"62201_CR98","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41586-022-04817-8","volume":"608","author":"M Chaffin","year":"2022","unstructured":"Chaffin, M. et al. Single-nucleus profiling of human dilated and hypertrophic cardiomyopathy. Nature 608, 174\u2013180 (2022).","journal-title":"Nature"},{"key":"62201_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v028.i05","volume":"28","author":"M Kuhn","year":"2008","unstructured":"Kuhn, M. Building predictive models in R Using the caret package. J. Stat. Softw. 28, 1\u201326 (2008).","journal-title":"J. Stat. Softw."},{"key":"62201_CR100","doi-asserted-by":"publisher","first-page":"e14325","DOI":"10.2196\/14325","volume":"7","author":"P Wu","year":"2019","unstructured":"Wu, P. et al. Mapping ICD-10 and ICD-10-CM codes to phecodes: workflow development and initial evaluation. JMIR Med. Inf. 7, e14325 (2019).","journal-title":"JMIR Med. Inf."},{"key":"62201_CR101","doi-asserted-by":"crossref","unstructured":"Townsend, P., Phillimore, P. & Beattie, A. Health and Deprivation: Inequality and the North (Taylor & Francis, 2023).","DOI":"10.4324\/9781003368885"},{"key":"62201_CR102","doi-asserted-by":"publisher","first-page":"e010119","DOI":"10.1161\/CIRCHEARTFAILURE.122.010119","volume":"16","author":"K Amancherla","year":"2023","unstructured":"Amancherla, K. et al. Single-nuclear RNA sequencing of endomyocardial biopsies identifies persistence of donor-recipient chimerism with distinct signatures in severe cardiac allograft vasculopathy. Circ. Heart Fail 16, e010119 (2023).","journal-title":"Circ. Heart Fail"},{"key":"62201_CR103","doi-asserted-by":"publisher","first-page":"H797","DOI":"10.1152\/ajpheart.00374.2022","volume":"323","author":"DM Eaton","year":"2022","unstructured":"Eaton, D. M. et al. Sex-specific responses to slow progressive pressure overload in a large animal model of HFpEF. Am. J. Physiol. Heart Circ. Physiol. 323, H797\u2013H817 (2022).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"62201_CR104","doi-asserted-by":"crossref","unstructured":"Fleming, S. J. et al. Unsupervised removal of systematic background noise from droplet-based single-cell experiments using CellBender. Nat. Methods 20, 1323\u20131335 (2023).","DOI":"10.1038\/s41592-023-01943-7"},{"key":"62201_CR105","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cels.2018.11.005","volume":"8","author":"SL Wolock","year":"2019","unstructured":"Wolock, S. L., Lopez, R. & Klein, A. M. Scrublet: computational identification of cell doublets in single-cell transcriptomic data. Cell Syst. 8, 281\u2013291 e289 (2019).","journal-title":"Cell Syst."},{"key":"62201_CR106","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"62201_CR107","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27150-6","volume":"12","author":"M Buttner","year":"2021","unstructured":"Buttner, M., Ostner, J., Muller, C. L., Theis, F. J. & Schubert, B. scCODA is a Bayesian model for compositional single-cell data analysis. Nat. Commun. 12, 6876 (2021).","journal-title":"Nat. Commun."},{"key":"62201_CR108","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.aaz1776","volume":"369","author":"GTEx Consortium","year":"2020","unstructured":"GTEx Consortium The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science 369, 1318\u20131330 (2020).","journal-title":"Science"},{"key":"62201_CR109","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/s41588-020-0706-2","volume":"52","author":"D Zhou","year":"2020","unstructured":"Zhou, D. et al. A unified framework for joint-tissue transcriptome-wide association and Mendelian randomization analysis. Nat. Genet. 52, 1239\u20131246 (2020).","journal-title":"Nat. Genet."},{"key":"62201_CR110","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13690-5","volume":"11","author":"S Shah","year":"2020","unstructured":"Shah, S. et al. Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure. Nat. Commun. 11, 163 (2020).","journal-title":"Nat. Commun."},{"key":"62201_CR111","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/s41588-019-0409-8","volume":"51","author":"ER Gamazon","year":"2019","unstructured":"Gamazon, E. R., Zwinderman, A. H., Cox, N. J., Denys, D. & Derks, E. M. Multi-tissue transcriptome analyses identify genetic mechanisms underlying neuropsychiatric traits. Nat. Genet. 51, 933\u2013940 (2019).","journal-title":"Nat. Genet."},{"key":"62201_CR112","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03621-1","volume":"9","author":"Barbeira","year":"2018","unstructured":"Barbeira. et al. Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics. Nat. Commun. 9, 1825 (2018).","journal-title":"Nat. Commun."},{"key":"62201_CR113","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/ng.3506","volume":"48","author":"A Gusev","year":"2016","unstructured":"Gusev, A. et al. Integrative approaches for large-scale transcriptome-wide association studies. Nat. Genet. 48, 245\u2013252 (2016).","journal-title":"Nat. Genet."},{"key":"62201_CR114","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/ng.3367","volume":"47","author":"ER Gamazon","year":"2015","unstructured":"Gamazon, E. R. et al. A gene-based association method for mapping traits using reference transcriptome data. Nat. Genet. 47, 1091\u20131098 (2015).","journal-title":"Nat. Genet."},{"key":"62201_CR115","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41588-022-01051-w","volume":"54","author":"J Zhang","year":"2022","unstructured":"Zhang, J. et al. Plasma proteome analyses in individuals of European and African ancestry identify cis-pQTLs and models for proteome-wide association studies. Nat. Genet. 54, 593\u2013602 (2022).","journal-title":"Nat. Genet."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62201-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62201-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62201-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T05:06:35Z","timestamp":1757307995000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62201-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":115,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["62201"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-62201-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,26]]},"assertion":[{"value":"19 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Lindman is supported by R01HL164526 and R01AG073633 from the NIH, has received investigator-initiated research grant funding and consulted for Edwards Lifesciences, and consulted for Astra Zeneca, Medtronic, Kardigan, and Anteris. Dr. Perry has patents pending for proteomic signatures of fitness, lung, and liver disease. Dr. Amancherla is supported by an American Heart Association (AHA) Career Development Award (#929347), the NIH (K23HL166960), the Red Gates Foundation, and an International Society for Heart and Lung Transplantation Enduring Hearts Transplant Longevity Award. Dr. Amancherla has an institutional disclosure filed for spatial RNA biomarkers of transplant rejection and allograft health.\u00a0Dr. Gerszten is supported by a Leducq foundation grant (21CVD01). Dr. Nayor supported by R01HL156975 and R01HL131029 from the NIH. Dr. Gillam is an advisor Medtronic, Philips, and Egnite and oversees core lab contracts with Edwards Lifesciences, Medtronic, and Abbott (no direct compensation). Dr Dweck is supported by the British Heart Foundation (FS\/SCRF\/21\/32010) and is the recipient of the Sir Jules Thorn Award for Biomedical Research 2015 (15\/JTA). Dr. Das is a founder of Thryv Therapeutics and Switch Therapeutics with equity in both, and has research grants from Bristol Myers Squibb, National Institutes of Health (R35HL 105807). Dr. Gupta is supported by R01HL153607, R01HL154153-03, R01HL148661, R01AG034962, and R01HL145293 from the NIH and is patent holder (#11,079,394) for detection of angiopoietin-2 and thrombospondin-2 for the diagnosis of acute heart failure.\u00a0Dr. Miller is supported by the Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development. Dr. Tucker is supported by the NIH R01-HL170051. Dr. Gamazon is a consultant for Thryv Therapeutics, and is a co-inventor on pending patents or disclosures on cardiovascular diseases and phenotypes, and metabolic health, use of RNAs as therapeutics and diagnostic biomarkers in disease, and methods in metabolomics. Dr. Shah is supported by grants from the National Institutes of Health. Dr. Shah has equity ownership in and is a consultant for Thryv Therapeutics. Dr. Shah is a co-inventor on pending patents or disclosures on molecular biomarkers of fitness, lung disease, cardiovascular diseases and phenotypes, and metabolic health, use of RNAs (including spatial)\u00a0as therapeutics and diagnostic biomarkers in disease, and methods in metabolomics. Dr. Elmariah is supported by institutional research grants from the NIH (5R01HL151838), the Patient-Centered Outcomes Research Institute, Edwards Lifesciences, Medtronic, and Abbott. Dr. Elmariah is a consultant for Edwards Lifesciences and holds equity and is co-founder of Prospect Health. The remaining authors have no relevant disclosures.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6889"}}